41 %41% of clinicians knew saliva could be used in diagnosing HIV.
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 17 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
1 729 evidences · page 2 / 70
41 %41% of clinicians knew saliva could be used in diagnosing HIV.
NigeriaVIH/sidapublié 2019The Pan African medical journalPubMeddocument de 17 observations
84 %Of 425 patients that were traced, 355 (84%) were alive and 70 (16%) were dead.
NigeriaVIH/sidapublié 2019PloS onePubMeddocument de 8 observations
8 yearsThe median time to first birth after HIV diagnosis was 8 years.
NigeriaVIH/sidaobservé 2015publié 2020PloS onePubMeddocument de 4 observations
90 %Mother-to-child transmission accounts for 90% of all new paediatric HIV infections in Nigeria.
NigeriaVIH/sidapublié 2024BMC pregnancy and childbirthPubMeddocument de 8 observations
0,86 %Early infant diagnosis was positive for HIV among 13 infants (0.86%) of the 1,514 infants studied in Kano, northwest Nigeria.
NigeriaVIH/sidaobservé 2010 to 2016publié 2021Current HIV researchPubMeddocument de 6 observations
210 000 casesIn 2023, over 210,000 new HIV acquisitions occurred in Kenya, Mozambique, Nigeria, Uganda and Zambia.
Kenya · Mozambique · Nigeria · Ouganda · ZambieVIH/sidaobservé 2023publié 2025Journal of the International AIDS SocietyPubMeddocument de 2 observations
29 %Menstrual irregularities were found to be prevalent among Nigerian women living with HIV, varying from 29% to 76% across different regions.
NigeriaVIH/sidapublié 2024Reproductive healthPubMed
29 %Of the 483 patients with tuberculosis treated at the health facility between 2018 and 2022, 29.0% had TB/HIV coinfection.
Nigeriatuberculose · VIH/sidaobservé 2018-2022publié 2024BMJ openPubMeddocument de 6 observations
0,01 aORClients on six-month multi-month dispensing had an adjusted odds ratio of 0.01 for interruption of antiretroviral therapy.
NigeriaVIH/sidapublié 2021BMC public healthPubMeddocument de 12 observations
16,3 %The prevalence of Herpes Simplex Virus Type-2 was 16.3% among HIV seronegative women.
NigeriaHerpes Simplex Virus Type-2 · VIH/sidapublié 2022Current HIV researchPubMeddocument de 4 observations
47,7 %47.7% of the study participants were HIV positive.
NigeriaVIH/sidaobservé 2020–2022publié 2023BMC cancerPubMeddocument de 14 observations
32,7 %Mortality among HIV/AIDS admissions was 32.7%.
NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations
10 patientsTen patients had resistance to their first-line drug(s).
NigeriaVIH/sidapublié 2020BMC microbiologyPubMeddocument de 7 observations
51,5 %HIV prevalence among transgender women (TGW) in Abuja and Lagos, Nigeria was 51.5%.
NigeriaVIH/sidaobservé 2013 to 2020publié 2022Journal of the International AIDS SocietyPubMeddocument de 20 observations
56 %Of 6108 registered patients, 3397 (56%) were lost to follow-up from the Lagos University Teaching Hospital antiretroviral program.
NigeriaVIH/sidapublié 2019PloS onePubMeddocument de 8 observations
1,4 odds_ratioForced sexual initiation was significantly associated with infrequent condom use (OR = 1.4, 95% CI = 1.1–2.1) among youth in Nigeria, Uganda, and Zambia.
Nigeria · Ouganda · ZambieVIH/sidaobservé 2014 and 2015publié 2019Child abuse & neglectPubMeddocument de 8 observations
79,3 %Among men living with HIV in Kano, Nigeria, 79.3% desired more children, compared to 91.1% of HIV-negative/untested controls.
NigeriaVIH/sidapublié 2020International journal of behavioral medicinePubMeddocument de 6 observations
10,1 %The overall HIV prevalence among 3229 study participants was 10.1%.
NigeriaVIH/sidaobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations
249 individualsAmong HIV-positive patients in Ilorin, Nigeria, 249 (64.8%) used active coping as a coping strategy.
NigeriaVIH/sidapublié 2021Nigerian journal of clinical practicePubMeddocument de 7 observations
9,4 %Comprehensive HIV knowledge was low among young adolescents in Akwa Ibom State, Nigeria, at 9.4%.
NigeriaVIH/sidaobservé 2017publié 2020BMC public healthPubMeddocument de 5 observations
7,11 AORParticipants with pulmonary TB had a higher likelihood of favorable TB treatment outcome compared to those with extrapulmonary TB (adjusted odds ratio = 7.110, 95% confidence interval = 1.506–33.565).
Nigeriatuberculose · VIH/sidapublié 2024The Pan African medical journalPubMeddocument de 5 observations
4,7 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 4.7% ever used intrauterine insemination as a safer conception method.
NigeriaVIH/sidapublié 2019International journal of health policy and managementPubMeddocument de 10 observations
35,4 %Among individuals initiated on antiretroviral therapy more than 14 days after HIV diagnosis, 35.4% were lost to follow-up by 12 months in Nigeria.
NigeriaVIH/sidapublié 2023PloS onePubMeddocument de 3 observations
13,4 yearsAmong HIV-positive women, PhenoAge acceleration (PhenoAA) was on average 13.4 years higher in women with invasive cervical cancer compared to cancer-free women.
Nigeriacancer du col de l'utérus · VIH/sidapublié 2022Frontiers in public healthPubMeddocument de 4 observations
481 casesAmong 16,727 female sex workers on antiretroviral therapy in Nigeria between 1 January 2016 and 31 August 2022, 481 (3%) had transferred to other clinics for ART by 31 August 2022.
NigeriaVIH/sidaobservé 2016-01-01 to 2022-08-31publié 2026BMC women's healthPubMeddocument de 11 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.